amlodipine has been researched along with calpain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barretto, OC; Dantas de Medeiros, TM; Mion, D; Nonoyama, K; Ortega, KC | 1 |
| Fang, JY; Li, C; Wang, H; Xu, J; Yao, H | 1 |
2 other study(ies) available for amlodipine and calpain
| Article | Year |
|---|---|
Normal erythrocyte calpain I activity on membrane proteins under near-physiological conditions in patients with essential hypertension.
Topics: Adult; Amlodipine; Ankyrins; Calcium-Binding Proteins; Calpain; Captopril; Case-Control Studies; Electrophoresis, Polyacrylamide Gel; Erythrocyte Membrane; Humans; Hypertension; Membrane Proteins | 2002 |
Repurposing screen identifies Amlodipine as an inducer of PD-L1 degradation and antitumor immunity.
Topics: Amlodipine; Animals; Antineoplastic Agents; B7-H1 Antigen; Beclin-1; Calpain; Drug Repositioning; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Mice; Neoplasms; Signal Transduction | 2021 |